Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Mesenchymal stem cell therapy (Primary) ; Mesenchymal stem cell therapy (Primary)
- Indications Spinal cord injuries
- Focus Therapeutic Use
- Sponsors BioStar; K-STEMCELL; R-Biopharm
- 01 Aug 2016 Status changed from recruiting to completed.
- 27 May 2014 New trial record